[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.19.31. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,145
Citations 0
Comment & Response
September 18, 2013

Statin Therapy for Hyperlipidemia

Author Affiliations
  • 1Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland
JAMA. 2013;310(11):1184-1185. doi:10.1001/jama.2013.276734

To the Editor We are concerned that a JAMA Patient Page1 regarding statin therapy for hyperlipidemia sent the wrong message to patients. We found this piece to be unbalanced. The authors failed to mention anything about the unequivocal benefit of statins in secondary prevention settings, but devoted a full paragraph to adverse effects.

In addition, at the end of the adverse effects paragraph, the last 2 sentences of the Patient Page discussed the controversial aspects of primary prevention: “a 2010 analysis combined the results of 11 studies and found that taking statins did not lower the death rate for people who did not have heart disease. If your physician recommends taking a statin, talk to him or her about the risks and benefits for your individual situation.”

First Page Preview View Large
First page PDF preview
First page PDF preview
×